Protagenic Therapeutics, Inc.\new Free Cash Flow (FCF) History (PTIX)
Protagenic Therapeutics, Inc.\new reported −$2.8M in free cash flow for fiscal 2026, an increase of $1.0M from the previous fiscal year.
View full Protagenic Therapeutics, Inc.\new company overviewProtagenic Therapeutics, Inc.\new free cash flow by year
| Fiscal year | Period ended | Free cash flow | Change | Growth | FCF margin |
|---|---|---|---|---|---|
| 2026 | 2026-03-31 | −$2.8M | $1.0M | — | — |
| 2023 | 2023-12-31 | −$3.9M | −$1.9M | — | — |
| 2022 | 2022-12-31 | −$2.0M | −$1.6M | — | — |
| 2015 | 2015-06-30 | −$379,000 | $412,000 | — | — |
| 2014 | 2014-06-30 | −$791,000 | — | — | — |
Protagenic Therapeutics, Inc.\new quarterly free cash flow
| Fiscal quarter | Period ended | Free cash flow | Change | YoY growth | FCF margin |
|---|---|---|---|---|---|
| Q4 2015 | 2015-06-30 | −$58,485 | $28,515 | — | — |
| Q3 2015 | 2015-03-31 | −$10,001 | $105,999 | — | — |
| Q2 2015 | 2014-12-31 | −$111,000 | $40,000 | — | — |
| Q1 2015 | 2014-09-30 | −$80,000 | $357,000 | — | — |
| Q4 2014 | 2014-06-30 | −$87,000 | $207,000 | — | — |
| Q3 2014 | 2014-03-31 | −$116,000 | $3.3M | — | — |
| Q2 2014 | 2013-12-31 | −$151,000 | — | — | — |
| Q1 2014 | 2013-09-30 | −$437,000 | — | — | — |
| Q3 2011 · Sep 30 | 2011-09-30 | −$294,000 | — | — | −2.39% |
| Q3 2011 · Sep 30 | 2010-09-30 | −$3.4M | — | — | −36.80% |
Protagenic Therapeutics, Inc.\new free cash flow growth trends
Protagenic Therapeutics, Inc.\new's latest reported quarter, Q4 2015, generated −$58,485 in free cash flow, an increase of $28,515 year over year.
What free cash flow means
Free cash flow is the cash a company generates from operations after capital expenditures. Positive FCF can fund dividends, buybacks, debt repayment, or reinvestment; negative FCF means capital spending exceeded operating cash flow for that period.
How free cash flow is calculated
TickerStat calculates free cash flow as SEC-reported operating cash flow minus capital expenditures. FCF margin equals free cash flow divided by revenue. Fiscal periods can differ from calendar years, so the tables include exact period-end dates.
Review Protagenic Therapeutics, Inc.\new filings at SEC.gov ↗